SEBIO Networking Program
To facilitate interactions with all of our Participating Companies, SEBIO will again make break out rooms available throughout the conference for scheduled meetings with these companies.
Meetings can be initiated by investors, established drug, device or diagnostic manufacturers and Conference Sponsors. Other service providers can initiate meetings after registering for the Networking Program.
To learn more about Networking, contact one of our co-chairs, Dennis Schafer, schaferdp@verizon.net, or Mary Henninger, Mary.Henninger@finnegan.com. To schedule meetings with one of our Participating Companies, contact Kristen Morris, kmorris@informedhorizons.com. If you are a service provider who would like to register for the Networking Program, contact Dave Poole, dpoole@informedhorizons.com.
The following companies have been selected to participate at this year’s Forum:
Main-Stage Companies
- Altea Therapeutics Corporation
The Altea Therapeutics PassPort® System is a breakthrough transdermal technology for the convenient and painless delivery of currently injected biologics from a small skin patch.
- Altor Bioscience Corporation
A company specializes in developing targeted immunotherapeutics including monoclonal antibodies and soluble T-cell receptor targeted therapeutics for cancer, infectious disease and inflammatory disease, with three agents in mid to late stage clinical development.
- ArteRain Medical
A medical device company developing an improved catheter system for the treatment of stroke that enables rapid removal of occlusions.
- CaloSyn Pharma, Inc.
A pharmaceutical company focused on developing intra-articular therapeutics for osteoarthritis using calcium channel blockers to inhibit the release of cartilage degrading enzymes.
- Catena Pharmaceuticals, Inc.
A drug discovery company developing its proprietary anti-proliferative G-protein coupled receptor antagonist compounds for the treatment of cancer and fibrosis.
- EGEN, Inc.
A biotechnology company specializing in DNA and RNAi delivery systems and therapeutics with its lead immunotherapeutic oncology product tested in clincal trials.
- GenerationOne, Inc.
A company that has developed the nation’s first fully-integrated, end-to-end wireless healthcare platform permitting individuals to actively manage their health and wellness using mobile devices.
- MedShape Solutions, Inc.
A medical device company commercializing implants made from shape memory polymer and alloy technologies to improve orthopedic procedures.
- NuMe Health, LLC.
A biotechnology company developing Medical Foods designed to address nutritional deficiencies that are associated with many illnesses.
- Pathfinder Therapeutics, Inc.
A company commercializing an image-guided navigation surgical system for abdominal procedures that can allow the surgeon to create and impliment a precise preoperative plan.
- RetinaSense
A medical device company specializing in devices for sensing active retinal tissue and providing a secondary signal to surgeons during vitreoretinal surgery to distinguish between healthy retinal tissue and tissue requiring removal.
- Visioneering Technologies, Inc.
An eyecare company developing solutions for presbyopia using “induced aperture” optical technology for contact lenses, LASIK, and Intraocular Lenses.
- Zirus, Inc.
A biotechnology company with a proprietary platform of over 1000 human host targets essential for viral replication and is rapidly and cost effectively developing repurposed drugs and preclinical small molecule antagonists to its platform to address all major antiviral markets, including pandemic/seasonal flu, HIV, HCV,
bio-terror threats, and broad spectrum antiviral drugs.
Early-Stage Companies
- Abeome Corporation
A monoclonal antibody discovery company developing therapeutics and biomarkers, focused currently on developing cancer therapeutic and diagnostic pipeline products in the ovarian-cancer arena.
- AccuRx, Inc.
A drug delivery company focused on safe, convenient and programmed delivery of prescription drugs to the eye using its hydrogel and microdevice technologies with applications for glaucoma and diabetic retinopathy.
- Cerene Biomedics Incorporated
A medical device company developing an implantable thermoelectric device that will treat focal epilepsy through cooling the surface of the brain.
- DiscoveryBioMed, Inc.
A human cell engineering and human cell-based drug discovery company focused on using disease-relevant human cell platforms to accelerate drug discovery for multiple and different chronic human diseases.
- EntoGenetics
A biotechnology company that has transferred the spider gene for silk production into the common silk worm for large scale, inexpensive spider silk production for application in the technical textile field.
- Heat Biologic
A clinical stage pharmaceutical company focused on the development of novel immunotherapies to treat a wide range of cancers and other disorders.
- Immunologix, Inc.
A human antibody discovery and development company specializing in transforming naïve B-cells to produce fully human antibodies that can target any and all antigens.
- Ion Surgical Technologies, Inc.
A medical device company specializing in products for new arthroscopic methods of ACL and rotator cuff repair to eliminate or complement currently used implants.
- Key Genomics
A company that develops diagnostic assays based on novel multi-gene molecular signatures predicting patient-specific response to various cancer treatments.
- Kiyatec, LLC
A company that captures high value information that reduces the time and cost associated with drug discovery and personalized medicine by commercializing advanced three-dimensional (3-D) cell-based diagnostics.
- Ligamar, Inc.
A biomaterials company that provides cost effective solutions for the purification of therapeutic bioproducts and the analysis, detection and removal of pathogens and biohazards from process streams.
- MicroVide
A company developing a transportable and disposable diagnostic system to measure real-time biological pathways or drug levels without expensive imaging or sensing systems.
- Nelson Pharmaceuticals, LLC
A specialty pharmaceutical company specializing in reformulating drugs to treat chronic diseases for sale or license to pharmaceutical companies familiar with the drugs to fill holes in drug development pipelines.
- Phthisis Diagnostics
A biotechnology company developing molecular diagnostics for infectious diseases with superior quality, ease-of-use, and cost savings compared to current diagnostics.
- Synereca Pharmaceuticals
A spin-out pharmaceutical company developing combination products that combat bacterial resistance to current antibiotics, with its intial focus on inhibiting RecA, a key enzyme in bacterial DNA repair.
- X-Ray Robotics
A medical device company specializing in a robot-based medical imaging system that produces multi-dimensional images of human joints while the patient is in motion for the diagnosis and treatment of musculoskeletal and chronic pain conditions.
BioPlan Companies
- ARISTE Medical
A drug delivery company developing novel coatings that enable controlled delivery of therapeutic agents on implantible medical devices.
(University of Tennessee)
- Cytex Therapeutics
A device company developing bioartificial cartilage implants generated from in vitro culture of the patient's stem cells on a three-dimensional custom-woven scaffold that allow the resurfacing of an entire joint using a minimally invasive surgery.
(Duke University)
- Alaeras, Inc.
A drug delivery company developing a low cost, disposable, nasal vaccine device platform and manufacturing a dry powder nasal vaccine not requiring refrigeration suitable for all markets, and, in particular, developing countries.
(UNC, Duke, Global Vaccine Initiative, Hamner Institutes)
- EpiEP
A medical device company developing an access needle system for minimally invasive treatment of cardiac conditions using a combination of fluoroscopic imaging and pressure sensing monitors to access the pericardial cavity around the heart. (University of Virginia)
- NeuroScience Pharmaceuticals Inc.
A clinical stage company dedicated to the development of a pipeline of neurosteroid drugs for the treatment of brain disorders including therapeutic indications for schizophrenia, Post Traumatic Stress Disorder (PTSD), Traumatic Brain Injury (TBI), depression, Alzheimer's, and addiction.
(Duke University)
- Restorative Physiology Group
A medical device company developing orthopaedic implants made of thermally-activated shape memory materials for minimally invasive placement using catheters.
(Medical University of South Carolina)
- Scintigra, Inc.
A company developing diagnostic radio-pharmaceuticals for positron emission tomography (PET) and Single Photon Emission Computerized Tomography (SPECT) to detect and monitor diseases and disorders such as cancer, Alzheimer's disease, and heart disease. (Emory University)
- Compliant Therapeutics
A company developing ocular drug delivery systems using a cross-linking mechanism for the formation of nano- and microspherical structures for greater drug loading and controlled drug delivery for the treatment of glaucoma. (Vanderbilt University)
- TEGA Pharmaceuticals
A drug development company designing small compounds directed at a novel target, Autophagy, to treat bacterial infections and age-related diseases such as cancer and neurodegenerative disorders. (University of Florida College of Medicine)
The Investor Forum offers two opportunities for emerging life sciences companies to showcase their enterprises to the investment community.
The SEBIO Early-Stage Event is an opportunity for life sciences companies seeking their first round of venture capital and/or angel investment to gain exposure to and receive mentoring from active early-stage investors.
SEBIO Presenting Companies have generally completed at least one round of institutional financing. These companies are considered to be among the best life sciences deals in the Southeast, as determined by a Selection Committee comprised of regional and national venture capitalists. Each presenting company makes a ten-minute pitch to the full conference audience. |
